ZbigniewKazimierzWszolekMD
Neurology • Jacksonville, FLMovement Disorder, Neurophysiology, Neurodegenerative
Professor, Neurology, Mayo Medical School
Dr. Wszolek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4500 San Pablo Rd S
Jacksonville, FL 32224Phone+1 904-953-2000
Education & Training
University of Nebraska Medical Center College of MedicineResidency, Neurology, 1985 - 1989
Medical University of SilesiaClass of 1973
Certifications & Licensure
FL State Medical License 1998 - 2026
MN State Medical License 1989 - 2020
GA State Medical License 2014 - 2019
KY State Medical License 2014 - 2015
IA State Medical License 1986 - 2005
TN State Medical License 1996 - 2005
PA State Medical License 1987 - 1990- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Safety, Tolerability, and Pharmacokinetics of C2N-8E12 in Subjects With Progressive Supranuclear Palsy Start of enrollment: 2015 Jul 01
- A Study to Assess CSF1R-related Leukoencephalopathy After Stem Cell Transplantation Start of enrollment: 2020 Jul 21
- Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases Start of enrollment: 2017 Jul 17
Publications & Presentations
PubMed
- Current Landscape of Clinical Diagnosis in Multiple System Atrophy: A 15-Year Analysis From 2008 to 2022.Hiroaki Sekiya, Philip W Tipton, Miki Kawazoe, Shunsuke Koga, Aya Murakami
Neurology. 2024-12-10 - Prominent loss of striatal dopamine transporter binding in frontotemporal lobar degeneration with the MAPT N279K mutation present as early as at prodromal stage withou...Toji Miyagawa, Cynthia Vernon, Scott A Przybelski, Paul H Min, Julie A Fields
Parkinsonism & Related Disorders. 2024-11-01 - 1 citationsDopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa-Induced Dyskinesia.Yuri L Sosero, Sara Bandres-Ciga, Bart Ferwerda, Maria T P Tocino, Dìaz R Belloso
Movement Disorders. 2024-10-01
Journal Articles
- Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated with MAPT, GRN, and C9orf72 Pathogenic VariantsNupur Ghoshal, Neill R Graff-Radford, David S Knopman, Zbigniew K Wszolek, Joel H Kramer, Bradley F Boeve, Howard J Rosen, JAMA Network Open
Press Mentions
8 New Genetic Mutations Linked to Rare Cognitive Disorder Discovered by Mayo ClinicSeptember 27th, 2024- Researchers Identify Genetic Mutations for Rare Disorder Causing Cognitive DeclineSeptember 24th, 2024
- Looking Back on 2020: A Successful Year of Research at Mayo Clinic in FloridaJanuary 5th, 2021
- Join now to see all
Grant Support
- Core--ClinicalNational Institute Of Neurological Disorders And Stroke2004–2008
- Core--Clinical /PathologyNational Institute Of Neurological Disorders And Stroke2000–2002
Professional Memberships
- Member
Other Languages
- Polish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
